As of December 2021, 17 projects have been selected for funding under the RHU, including the EpCART project, which has received nearly 10 million euros. Led by Dr. Sebastian Amigorena, one of the Mnemo Therapeutics scientific co-founders and head of the Immune Responses and Cancer team at Institut Curie, the EpCART project aims to obtain clinical validation of a new approach of CAR-T cell immunotherapy.